Profenamine
From Wikipedia, the free encyclopedia
 |
|
|
Profenamine
|
|
| Systematic (IUPAC) name | |
| N,N-diethyl-1-(10H-phenothiazin-10-yl)propan-2-amine | |
| Identifiers | |
| CAS number | |
| ATC code | N04 |
| PubChem | |
| DrugBank | |
| Chemical data | |
| Formula | C19H24N2S |
| Mol. mass | 312.473 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Protein binding | 93% |
| Metabolism | ? |
| Half life | 1 to 2 hours |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Profenamine hydrochloride (INN, also known as ethopropazine) is a medication derived from phenothiazine. It is primarily used as an antidyskinetic to treat parkinsonism. It is sold under the trade names Parsidol in the United States and Parsidan in Canada.
 |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
|
|||||||||||
